International Clinical Trial: The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114640) titled 'The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Far Eastern Memorial Hospital

Condition: Urinary Bladder, Overactive

Intervention: Drug: Mirabegron 25mg Drug: Solifenacin 5 mg Drug: Tolterodine 4 mg

Recruitment Status: Not recruitin...